Betul Hatipoglu, MD
Showing of 7 results
The Intersection of Liver Disease and Metabolic Dysfunction
Innovations in Diabetes & Endocrinology | Summer 2026
University Hospitals Is the First Ohio Site to Offer Breakthough Lantidra Treatment for Type 1 Diabetes
Innovations in Diabetes & Endocrinology | Spring 2026
University Hospitals Launches Diabetes on Demand Virtual Care Program
Innovations in Diabetes & Endocrinology | Spring 2026
Addressing the Psychological Impact of Diabetes
Innovations in Diabetes & Metabolic Care | Spring 2025
FDA Approval of Islet Cell Transplant Marks Milestone for UH’s Leading Endocrinologist
Innovations in Diabetes & Metabolic Care | Fall 2024 In 2023, the U.S. Food and Drug Administration (FDA) approved Lantidra™ (donislecel), a breakthrough allogeneic (donor) pancreatic islet cellular therapy for individuals with Type 1 diabetes...
Breaking the Silence: Understanding Diabetes-Related Depression
Innovations in Diabetes & Metabolic Care | Winter 2024
Results are loading...